Valuation
- Market cap
- 145,000
- Revenue TTM
- $0
- Net income TTM
- $-2,180,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 2,909,400
- Avg volume
- 663,434
- Day's range
- $0.00 – $0.00
- Shares out
- 1,445,713,000
- Stochastic %K
- 50%
- Beta
- -1.02
- Analysts
- —
- Price target
- $0.25
Company profile
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used...
Show more
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 800 489 4774
- Website
- https://www.endonovo.com
- Address
- 6320 Canoga Avenue, 15th Floor, Woodland Hills, United States
Latest news
No headlines yet.
